Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey

Francesco Ursini, Jacopo Ciaffi, Luana Mancarella, Lucia Lisi, Veronica Brusi, Carlotta Cavallari, Martina D’Onghia, Anna Mari, Elena Borlandelli, Jacopo Faranda Cordella, Micaela La Regina, Pasquale Viola, Piero Ruscitti, Marco Miceli, Roberto De Giorgio, Nicola Baldini, Claudio Borghi, Alessandro Gasbarrini, Annamaria Iagnocco, Roberto Giacomelli, Cesare Faldini, Maria Paola Landini, Riccardo Meliconi

10.1136/rmdopen-2021-001735

August 23, 2021

After 25 years of drug development, do we know JAK?

Mahta Mortezavi, David A Martin, Hendrik Schulze-Koops

10.1136/rmdopen-2022-002409

July 13, 2022

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes

Iain B McInnes, Laura M Sawyer, Kristen Markus, Corinne LeReun, Celia Sabry-Grant, Philip S Helliwell

10.1136/rmdopen-2021-002074

March 23, 2022

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

James M Gwinnutt, Maud Wieczorek, Javier Rodríguez-Carrio, Andra Balanescu, Heike A Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli, Savia de Souza, Annette de Thurah, Thomas E Dorner, Rikke Helene Moe, Polina Putrik, Lucía Silva-Fernández, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana Zlatković-Švenda, Francis Guillemin, Suzanne M M Verstappen

10.1136/rmdopen-2021-002167

June 2, 2022

Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up

Benjamin Sornrung Naovarat, Gloria Salazar, Mariko Ishimori, Francis M Williams, John D Reveille

10.1136/rmdopen-2022-002282

July 21, 2022

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations

Rory C Monahan, Michelle D van den Beukel, Nicole V Borggreven, Rolf Fronczek, Tom W J Huizinga, Margreet Kloppenburg, Gerda M Steup-Beekman, Leendert A Trouw

10.1136/rmdopen-2021-002079

April 21, 2022

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Désirée van der Heijde, Atul Deodhar, Walter P Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae-Hwan Kim, Mitsumasa Kishimoto, Andrew J Östör, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter K Wung, In-Ho Song

10.1136/rmdopen-2022-002280

July 27, 2022

Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study

Sjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Mohammad Kazim Khan, Peter M Villiger, Matthew A Brown

10.1136/rmdopen-2022-002208

July 22, 2022

‘Difficult to treat’ rheumatoid arthritis: current position and considerations for next steps

Yvonne Tan, Maya H Buch

10.1136/rmdopen-2022-002387

July 27, 2022

Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database

Katja Thiele, Katinka Albrecht, Angela Zink, Martin Aringer, Kirsten Karberg, Susanna Späthling-Mestekemper, Ulrich von Hinüber, Johanna Callhoff

10.1136/rmdopen-2022-002342

July 6, 2022

Most Read Articles